Abstract:Protein drugs are of great importance in maintaining the normal functioning of living organisms. Indeed, they have been instrumental in combating tumors and genetic diseases for decades. Among these pharmaceutical agents, those that target intracellular components necessitate the use of therapeutic proteins to exert their effects within the targeted cells. However, the use of protein drugs is limited by their short half-life and potential adverse effects in the physiological environment. The advent of nanoparticles offers a promising avenue for prolonging the half-life of protein drugs. This is achieved by encapsulating proteins, thereby safeguarding their biological activity and ensuring precise delivery into cells. This nanomaterial-based intracellular protein drug delivery system mitigates the rapid hydrolysis and unwarranted diffusion of proteins, thereby minimizing potential side effects and circumventing the limitations inherent in traditional techniques like electroporation. This review examines established protein drug delivery systems, including those based on polymers, liposomes, and protein nanoparticles. We delve into the operational principles and transport mechanisms of nanocarriers, discussing the various considerations essential for designing cutting-edge delivery platforms. Additionally, we investigate innovative designs and applications of traditional cytosolic protein delivery systems in medical research and clinical practice, particularly in areas like tumor treatment, gene editing and fluorescence imaging. This review sheds light on the current restrictions of protein delivery systems and anticipates future research avenues, aiming to foster the continued advancement in this field.

Protein-Mimicking Nanoparticles for a Cellular Regulation of Homeostasis

Protein‐Mimicking Nanoparticles in Biosystems

Functional Protein-Based Bioinspired Nanomaterials: from Coupled Proteins, Synthetic Approaches, Nanostructures to Applications

Progress in Nanoparticle-Based Regulation of Immune Cells.

Towards understanding of nanoparticle–protein corona

Nanocarriers for intracellular delivery of proteins in biomedical applications: strategies and recent advances

Computational Studies on the Interactions of Nanomaterials with Proteins and Their Impacts

Protein-guided biomimetic nanomaterials: a versatile theranostic nanoplatform for biomedical applications

Nanoparticle protein corona: from structure and function to therapeutic targeting

A Novel Intracellular Protein Delivery Platform Based on Single-Protein Nanocapsules

Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects

Interplay Between Nanomedicine And Protein Corona

Mesoporous Silica Nanoparticles for Protein Protection and Delivery

Biomedical Applications of Cell Membrane‐Based Biomimetic Nano‐Delivery System

Biomineralized Metal–Organic Framework Nanoparticles Enable Intracellular Delivery and Endo-Lysosomal Release of Native Active Proteins

Tailoring nanocarriers for intracellular protein delivery.

Beyond the promise: Exploring the complex interactions of nanoparticles within biological systems

Characterization and Biomedical Application Opportunities of the Nanoparticle's Protein Corona

Biofunctionalization of Nanomaterials

Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine

Functional Protein–organic/inorganic Hybrid Nanomaterials